{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN69u_sKDA","lastupdate":"2022-11-18T00:00:00.000Z","update_date":"2022-11-18T00:00:00.000Z","lastModified":"Sep 7, 2024","active":1,"confidence_score":91,"confidence_score_reason":"markets, not claimed","urlname":"leukodx","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$j0vJVLCK1R1WZAO8c3zkkK9Pv958pXcqPK86x8JbqEfbkiKtooLQ49","name":"Accellix","oneliner":"Cell Therapy Quality Control","registrar":"514248251","website":"https://www.accellix.com","careerspage":"","founded_month":3,"founded_year":2009,"formernames":["LeukoDx"],"sociallinks":{"twitter":"","youtube":"https://www.youtube.com/channel/UCViMRT-DKhzvqevPlWZnxHQ","facebook":"https://www.facebook.com/Accellix-by-LeukoDx-1630405383882153","linkedin":"https://www.linkedin.com/company/19221336","instagram":""},"social":["https://www.facebook.com/Accellix-by-LeukoDx-1630405383882153","https://www.linkedin.com/company/19221336","https://www.youtube.com/channel/UCViMRT-DKhzvqevPlWZnxHQ"],"flattenedsociallinks":"https://www.facebook.com/Accellix-by-LeukoDx-1630405383882153|https://www.linkedin.com/company/19221336|https://www.youtube.com/channel/UCViMRT-DKhzvqevPlWZnxHQ","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"51-200","employees_exact":70,"patent":1,"raised":18727000,"stage":"D","public_stage":"D","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["LeukoDx"],"about":"Accellix's mission is to provide quick and accurate flow cytometry results in a compact and easy-to-use platform designed for use on the manufacturing floor and at the point of care.\n\nThe Accellix platform enables its partners in the field of cell therapy to meet their critical quality control requirements as they advance life-changing therapies benefiting patients worldwide.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97226744422","country":null,"address":{"israeli":[{"id":"699969c9-d0cc-4adc-8940-84f1fde4b916","city":"Jerusalem","type":null,"address":"Shlomo Momo Ha'levi 5, Jerusalem, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"76b02233-4cea-4400-a173-802b879ed864","city":"San Jose","address":"2385 Bering Drive, San Jose, CA, USA","country":"United States","placeid":null}]},"headquarter_address":null,"district":"Jerusalem District","news":[{"id":"3780c211-fce2-43db-bea2-be46b67e98b9","date":"May 11, 2021","link":"https://www.businesswire.com/news/home/20210511005258/en/Accellix-Expands-its-Leadership-Team","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"SjIQC8E597fb9fCUi5ZWkDBQJzFfwUo15eT4VTL2zRfYkbvh86dZAX","news_summary":"Accellix Expands its Leadership Team","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"8cd64070-0610-42b6-ac8d-f9becd02bb15","date":"Jun 11, 2020","link":"https://www.businesswire.com/news/home/20200611005290/en/Accellix-Cell-Therapy-QC-Company-Raises-9.5","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"rbmUby6C9N4whnnYkDAo2NMqQcts52GvVL2hQnjoPCjHdP661V6z44","news_summary":"Accellix, the Cell Therapy QC Company Raises $9.5 Million Series D Round","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"ae3d79be-f251-4c1d-92e2-0625a9c0f6cd","date":"Apr 29, 2020","link":"https://www.businesswire.com/news/home/20200429005232/en/Accellix-Announces-Generation-Accellix-Instrument-Consumable-Simplify","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"c2tQ76CzODa6VlVuMsC0dNlsjyYJWVVpMgTzu6uAR5p6u6l87U5ZNE","news_summary":"Accellix, Inc. Announces Their Next Generation Accellix Instrument and Consumable to Further Simplify and Automate the QC Workflow in Cell Therapy Manufacturing","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"5ff5a1f5-9358-4de5-99e6-d36899374bbd","date":"Jan 15, 2020","link":"https://www.businesswire.com/news/home/20200115005163/en/Accellix-Announces-Appointment-Nir-Nimrodi-Chairman-Chief","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"T0azrywtm82ID00pkwOWuuD5Jhg4CoM8kJ1s8UNL8pjTgRKQUofzNj","news_summary":"Accellix, Inc. Announces the Appointment of Nir Nimrodi as Chairman and Chief Executive Officer. Nimrodi Will Lead the Company's Accelerated Growth as It Launches Custom and Standardized Panel Assays to Be Used by Its Expanding Installed Base.","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"5ff5a1f5-9358-4de5-99e6-d36899374bbd","date":"Jan 15, 2020","link":"https://www.businesswire.com/news/home/20200115005163/en/Accellix-Announces-Appointment-Nir-Nimrodi-Chairman-Chief","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"XYDvi4uvzUBJ9LXzvS90yq31lkRJ52pL8dd3bEXkcwy62u7bAYzIix","news_summary":"Accellix, Inc. Announces the Appointment of Nir Nimrodi as Chairman and Chief Executive Officer. Nimrodi Will Lead the Company's Accelerated Growth as It Launches Custom and Standardized Panel Assays to Be Used by Its Expanding Installed Base.","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"5b37de3d-426f-4532-ac30-51dd16f98244","date":"Oct 16, 2019","link":"https://www.globenewswire.com/news-release/2019/10/16/1930390/0/en/Orgenesis-Announces-Co-Development-Agreement-with-Accellix.html","source":"www.globenewswire.com","visible":1,"analysis":{"tags":"co-development agreement","company":"Orgenesis Inc.","layoffs":null,"summary":"Orgenesis Inc. has entered into a co-development agreement with Accellix, Inc. to integrate Accellixs proprietary optic system, cartridges, reagents, and software into Orgenesis Point of Care cellular therapy processing services and platform. The integration aims to advance Orgenesis quality control systems. The financial details of the agreement were not disclosed. Orgenesis POCare platform is designed to collect, process, and supply cells within the patient care location for therapeutic treatments. The Accellix assay delivery platform enhances the quality control aspects of Orgenesis POCare platform. The partnership is expected to lower costs and bring autologous therapies to patients in a cost-effective, high-quality, and scalable manner.","partners":"Accellix, Inc.","customers":null,"investors":null,"confidence":8,"key_topics":["Agreement","Integration","Quality Control","Cellular Therapy","Point of Care"],"date_of_event":"October 16, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"a335AmnFa0bF8ojX2a5zqx7nF72G4DIqBZhTQLxWWd7X19YIQGhfng","news_summary":"Orgenesis Announces Co-Development Agreement with Accellix","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"da064a8c-ba29-4e67-811c-eeda75efe598","date":"Jul 25, 2019","link":"https://www.businesswire.com/news/home/20190725005177/en/Accellix-Expands-Leadership-Team-Announces-Change","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"bv3HbUsHpeKvg5r3ctmorR5ZlJ3oJirKPyjCGLsawjOkJHtnbtYF25","news_summary":"Accellix, Inc Expands Leadership Team and Announces Name Change","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"679f8e17-bf59-408c-9eb7-1a4262cc924a","date":"Dec 6, 2018","link":"https://www.prnewswire.com/news-releases/emosis-and-accellix-announce-intent-to-form-a-joint-venture-emocellix-894235866.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"joint venture","company":"Emosis","layoffs":null,"summary":"Emosis and Accellix have signed a letter of intent to form a joint venture called EmoCellix. The joint venture will focus on marketing a complete solution for hemostasis cytomolecular diagnostics. EmoCellix will integrate Emosis novel hemostasis cytomolecular diagnostic tests with Accellixs innovative assay delivery platform. The joint venture aims to provide a complete solution for on-demand point-of-care hemostasis and thrombosis diagnostics. Emosis and Accellix will each own 50% of the joint venture. Customers will still have the option to purchase non-integrated products and services from both companies.","partners":["Accellix"],"customers":null,"investors":null,"confidence":9,"key_topics":["EmoCellix","hemostasis cytomolecular diagnostics","joint venture","Accellix","assay delivery platform"],"date_of_event":"December 6, 2018","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"EIfJtnV9qYXlAsxU6RanKvfDkdaj7MDmvgHUo79zugkwkv13tDokRo","news_summary":"Emosis and Accellix Announce Intent to Form a Joint Venture, EmoCellix","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"2041685e-f57f-4dbf-b444-b54bcb4ca8c1","date":"Mar 16, 2016","link":"http://www.marketwired.com/press-release/leukodx-ge-healthcare-enter-agreement-explore-solutions-cell-characterization-cell-therapy-2106534.htm","source":"www.marketwired.com","visible":1,"analysis":{"tags":"Unknown","company":"Unknown","layoffs":"Unknown","summary":"The article does not provide any information about a specific company or event.","partners":"Unknown","customers":"Unknown","investors":"Unknown","confidence":5,"key_topics":[],"date_of_event":"Unknown","valuation_amount":"Unknown","impact_on_company":"Unknown","investment_amount":"Unknown","structured_issues":[],"acquisition_amount":"Unknown","entityGrowthIconPath":"none;"},"sentiment":"Unknown","analysisId":"a46hMjReluyFRFcbpVLo90tke89N3ZU16ZeHxmHQmQbdleyfLvqSYI","news_summary":"http://www.marketwired.com/press-release/leukodx-ge-healthcare-enter-agreement-explore-solutions-cell-characterization-cell-therapy-2106534.htm","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"220dd7d9-5d52-49eb-8f81-043d260fa03f","date":"Jun 16, 2014","link":"http://finance.yahoo.com/news/leukodx-inc-closes-7m-financing-130000091.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"financing","company":"LeukoDx Inc.","layoffs":null,"summary":"LeukoDx Inc. has secured $7 million in new financing from Axcel Partners and individual investors. The funding will be used to accelerate the companys plans to bring the Accellix platform and rapid sepsis test to market. LeukoDx has also appointed Mark Chess and Seymour Liebman to serve as members of the Board of Directors. The companys mission is to deliver cost-effective, highly sensitive, and actionable diagnostic information at the point of care through its automated IVD flow cytometry platform. The Accellix platform and the Accellix Rapid Sepsis test are the companys first applications.","partners":null,"customers":null,"investors":"Axcel Partners, individual investors","confidence":9,"key_topics":["financing","Accellix platform","rapid sepsis test","new investors","Board of Directors"],"date_of_event":"June 16, 2014","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$7 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"CPitJ0mpQo7yGGDEZsjNQStVcS4FDsE1dbwS4BabBw7zs2uk3ZcKiM","news_summary":"LeukoDx Inc. Closes $7M Financing Round;Appoints Seymour Liebman & Mark Chess to BOD","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"73baf83c-e9c4-402d-b8a8-a8e9fe990c79","date":"Apr 12, 2012","link":"https://www.genomeweb.com/mdx/leukodx-closes-16m-financing-tranche-inks-agreements-8m#.W-1HIegzaUk","source":"www.genomeweb.com","visible":1,"analysis":{"tags":"investment, partners","company":"LeukoDx","layoffs":null,"summary":"LeukoDx has secured commitments of up to $8 million in investments to develop its point-of-care platform for delivering flow cytometry in vitro diagnostic results. The initial $1.6 million tranche has been closed, and the remaining investment will depend on reaching certain milestones within the next two years. The company is also developing an assay for CD64 neutrophil activation under a licensing deal with Trillium Diagnostics, which will allow for rapid clinical diagnosis in various patient settings. LeukoDx is seeking partnerships with biotechnology and IVD companies to expand the menu for its platform.","partners":"Trillium Diagnostics","customers":null,"investors":"Unnamed US private equity group, European life science investor, historical investors","confidence":9,"key_topics":["Flow cytometry technology","Investment","Point-of-care platform","Assay development","Partnerships"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$8 million","structured_issues":["Investment","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"NYT7WJlS8qaY8HOJ1FtTnpXuCGF2WjhJHGO0SYfSC75IAl1SRYe1fk","news_summary":"LeukoDx Closes $1.6M Financing Tranche, Inks Agreements for up to $8M","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":10,"techcommunityinvolvement":null,"mediagallery":[{"id":"f1ed7e63-dc1a-408b-b72b-a3baacfeb9b5","timestamp":"2015-01-21 09:06:06.000000","resources_type":1,"resources_title":"","resources_file_name":"$zD0v1fnZPhcWjVOr4Z6bJJ8xQBgLGxcgfsceuGVm3OFx8moVmmKTVP","alt":"","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$zD0v1fnZPhcWjVOr4Z6bJJ8xQBgLGxcgfsceuGVm3OFx8moVmmKTVP","url":"https://storage.googleapis.com/clean-finder-353810/$zD0v1fnZPhcWjVOr4Z6bJJ8xQBgLGxcgfsceuGVm3OFx8moVmmKTVP"}],"tags":["medical-technologies","hospitals","real-time","medical-devices","laboratories","critical-care","blood-test","biomarkers","diagnostics","operating-rooms","data-analytics","software-development","doctors","immunotherapy"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpscQIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lv-484LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If81MwLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Clinical Trial","products":["Accellix HLA-DR","Accellix CD64"],"geomarkets":["Europe"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":3,"lastfunding":"$9.5M","totalrounds":7,"fundingstage":"D","totalfunding":"$18.73M","publicinvestors":3,"lastpublicfunding":9500000,"totalpublicrounds":7,"totalpublicfunding":18727000},"team":[{"name":"Nir Nimrodi","email":"nnimrodi@accellix.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4P294pcKDA","bounced":false,"claimed":0,"founder":0,"urlname":"nir-nimrodi","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg4_vknAoM","position":"CEO","last_name":"Nimrodi","claimtoken":"hQmYMK92RPxaz73IWN3K6DEKI86fUjecP2G0g4SdqA3Bjf3mAf97We","first_name":"Nir","picturekey":null,"claimeddate":null,"linkedinurl":null,"unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-11-18 18:24:29.000000","initials":"NN","pictureurl":"/assets/empty-state.svg","linkedin-display":"none","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Harvey Kasdan","email":"hkasdan@accellix.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoOTy55AKDA","bounced":false,"claimed":0,"founder":1,"urlname":"harvey-kasdan-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICg5MzxmAoM","position":"Founder & CTO","last_name":"Kasdan","claimtoken":"da293d972ea9dec0ee92805adfc95a9f11fc268ab41332ea5e6d09d07ba67fab","first_name":"Harvey","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/harvey-kasdan-7780504/","unsubscribed":false,"is_activeuser":1,"additionalemail":"hkasdan@leukodx.com","claimedemaildate":"2020-03-24 18:42:26.000000","initials":"HK","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Rey Mali","email":"rmali@accellix.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4KPNgIEKDA","bounced":false,"claimed":0,"founder":0,"urlname":"rey-mali","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgo8_axAkM","position":"VP Sales & Marketing","last_name":"Mali","claimtoken":"uSVdXu27Evkc8XdIiY8xax7HifthYdHEWUEbKG74YWkDupWm4pT9IV","first_name":"Rey","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/rey-reut-mali-8b80044/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-11-18 18:26:37.000000","initials":"RM","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwPi8kYoKDA","fullname":"Ayelet Beazley"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLHD0KwIDA","fullname":"Sharon Shapira"},"biverifydate":"2020-03-24T00:00:00.000Z","crunchbaseid":"leukodx, accelix","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Arielle Smolin","creator_email":"ari.smolin@gmail.com","createdate":"2014-07-06T00:00:00.000Z","biverification":"Sharon Shapira","sectorverification":"Ayelet Beazley","affiliatedOrganizations":null,"timeline":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCZnuTbCgw","date":"Jun 2020","amount":"$9.5M","source":"https://www.businesswire.com/news/home/20200611005290/en/Accellix-Cell-Therapy-QC-Company-Raises-9.5","eventtype":"FundingRoundEvent","investment":[{"name":"Undisclosed Investor(s)","type":"Investor","amount":0,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"1a0c0b95-a9f6-4aab-ae24-7561b6952869","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":" bioMrieux,","type":"Company","amount":0,"hidden":true,"country":"France","fullurl":"/company_page/biomrieux","logokey":"$xp7gDjHZNzpvgZSoJ75biqG6pXw63SJquhFkWVvAZvBp9KymtAEpee","tagline":"","urlname":"/company_page/biomrieux","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODpo73RCgw","fundingtype":"Company","leadpartner":null,"investmentid":"5ed5b306-5f10-4287-b848-d2bd68b2d0df","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$xp7gDjHZNzpvgZSoJ75biqG6pXw63SJquhFkWVvAZvBp9KymtAEpee","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"D Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":9500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODk_PfXCgw","date":"Jun 2014","amount":"$7M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Axcel Partners","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/axcel-partners","logokey":"$XjjOmSEReyyXAOi7stxySkM7Rvjk5BrUI2220PU0GnswdNnx1bCNkz","tagline":"","urlname":"/investor_page/axcel-partners","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCkicymCAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"d2399a4a-2003-44e0-ba17-488c2734de59","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$XjjOmSEReyyXAOi7stxySkM7Rvjk5BrUI2220PU0GnswdNnx1bCNkz","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"B Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":7000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODE1cPoCAw","date":"Apr 2012","amount":"$1.6M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1600000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOC4juawCww","date":"Aug 2010","amount":"$250K","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":250000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODkwIfKCAw","date":"Jun 2010","amount":"$115K","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Debt Financing","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":115000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODEtbXiCQw","date":"Sep 2009","amount":"$377K","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":377000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkiZWICQw","date":"Jul 2009","amount":"Undisclosed","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"3/2009","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Accellix","logourl":"https://storage.googleapis.com/clean-finder-353810/$j0vJVLCK1R1WZAO8c3zkkK9Pv958pXcqPK86x8JbqEfbkiKtooLQ49","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$j0vJVLCK1R1WZAO8c3zkkK9Pv958pXcqPK86x8JbqEfbkiKtooLQ49","seoabout":"Accellix's mission is to provide quick and accurate flow cytometry results in a compact and easy-to-use platform designed for use on the manufacturing floo...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":3,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Diagnostics Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lv-484LDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Platforms & Interfaces","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","classificationName":"coretechnology"},{"depth":2,"name":"Software","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Consumers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Demographics & Family","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Babies","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If81MwLDA","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Laboratories","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpscQIDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Laboratories#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpscQIDA","TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA>Software#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Diagnostics Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lv-484LDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA>Babies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If81MwLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Diagnostics Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lv-484LDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA|2:>IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA/Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA|3:>IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA/Babies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If81MwLDA|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Laboratories#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpscQIDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA|2:>TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA/Software#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Medical Devices","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Diagnostics Devices","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Diagnostics Devices"}]}]}],"targetCustomer":[{"title":"Consumers","key":"0-0","path":"IndustryClassificationModel>Consumers","children":[{"title":"Demographics & Family","key":"0-0-0","path":"IndustryClassificationModel>Consumers>Demographics & Family","children":[{"title":"Babies","key":"0-0-0-0","path":"IndustryClassificationModel>Consumers>Demographics & Family>Babies"}]}]},{"title":"Healthcare & Life Sciences","key":"0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-1-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-1-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"},{"title":"Laboratories","key":"0-1-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Laboratories"}]}]}],"coreTechnology":[{"title":"Platforms & Interfaces","key":"0-0","path":"TechnologyClassificationModel>Platforms & Interfaces","children":[{"title":"Software","key":"0-0-0","path":"TechnologyClassificationModel>Platforms & Interfaces>Software"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Diagnostics Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lv-484LDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Platforms & Interfaces","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","classificationName":"coretechnology"},{"depth":2,"name":"Software","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1i8MIDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Consumers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Demographics & Family","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Babies","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If81MwLDA","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Laboratories","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PvpscQIDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Medical Devices","Diagnostics Devices"],"coreTechnology":["Platforms & Interfaces","Software"],"targetCustomer":["Consumers","Demographics & Family","Babies","Healthcare & Life Sciences","Healthcare","Providers","Laboratories"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCZnuTbCgw","date":"Jun 2020","amount":"$9.5M","source":"https://www.businesswire.com/news/home/20200611005290/en/Accellix-Cell-Therapy-QC-Company-Raises-9.5","eventtype":"FundingRoundEvent","investment":[{"name":"Undisclosed Investor(s)","type":"Investor","amount":0,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"1a0c0b95-a9f6-4aab-ae24-7561b6952869","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":" bioMrieux,","type":"Company","amount":0,"hidden":true,"country":"France","fullurl":"/company_page/biomrieux","logokey":"$xp7gDjHZNzpvgZSoJ75biqG6pXw63SJquhFkWVvAZvBp9KymtAEpee","tagline":"","urlname":"/company_page/biomrieux","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODpo73RCgw","fundingtype":"Company","leadpartner":null,"investmentid":"5ed5b306-5f10-4287-b848-d2bd68b2d0df","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$xp7gDjHZNzpvgZSoJ75biqG6pXw63SJquhFkWVvAZvBp9KymtAEpee","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"D Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":9500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODk_PfXCgw","date":"Jun 2014","amount":"$7M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Axcel Partners","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/axcel-partners","logokey":"$XjjOmSEReyyXAOi7stxySkM7Rvjk5BrUI2220PU0GnswdNnx1bCNkz","tagline":"","urlname":"/investor_page/axcel-partners","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCkicymCAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"d2399a4a-2003-44e0-ba17-488c2734de59","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$XjjOmSEReyyXAOi7stxySkM7Rvjk5BrUI2220PU0GnswdNnx1bCNkz","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"B Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":7000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODE1cPoCAw","date":"Apr 2012","amount":"$1.6M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1600000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOC4juawCww","date":"Aug 2010","amount":"$250K","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":250000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODkwIfKCAw","date":"Jun 2010","amount":"$115K","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Debt Financing","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":115000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODEtbXiCQw","date":"Sep 2009","amount":"$377K","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":377000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkiZWICQw","date":"Jul 2009","amount":"Undisclosed","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":0,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}